As of 2024-12-14, the EV/EBITDA ratio of Valeo Pharma Inc (VPH.TO) is -5.61. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. VPH.TO's latest enterprise value is 67.40 mil CAD. VPH.TO's TTM EBITDA according to its financial statements is -12.02 mil CAD. Dividing these 2 quantities gives us the above VPH.TO EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | EV/EBITDA |
| 2024-10-01 | -5.61 |
| 2024-09-30 | -5.61 |
| 2024-09-27 | -5.65 |
| 2024-09-26 | -5.65 |
| 2024-09-25 | -5.69 |
| 2024-09-24 | -5.73 |
| 2024-09-23 | -5.73 |
| 2024-09-20 | -5.77 |
| 2024-09-19 | -5.77 |
| 2024-09-17 | -5.77 |
| 2024-09-16 | -5.81 |
| 2024-09-13 | -5.77 |
| 2024-09-12 | -5.85 |
| 2024-09-11 | -5.69 |
| 2024-09-10 | -5.73 |
| 2024-09-09 | -5.73 |
| 2024-09-06 | -5.73 |
| 2024-09-05 | -5.73 |
| 2024-09-04 | -5.77 |
| 2024-09-03 | -5.77 |